Bioqual Income from Continuous Operations 2010-2024 | BIOQ
Bioqual income from continuous operations from 2010 to 2024. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change
Bioqual Annual Income from Continuous Operations (Millions of US $) |
2024 |
$0 |
2023 |
$1 |
2022 |
$5 |
2021 |
$ |
2020 |
$4 |
2019 |
$3 |
2018 |
$4 |
2017 |
$4 |
2016 |
$3 |
2015 |
$2 |
2013 |
$-0 |
2012 |
$0 |
2011 |
$0 |
2010 |
$0 |
2009 |
$1 |
Bioqual Quarterly Income from Continuous Operations (Millions of US $) |
2024-08-31 |
$-1 |
2024-05-31 |
$-1 |
2024-02-29 |
$0 |
2023-11-30 |
$0 |
2023-08-31 |
$1 |
2023-05-31 |
$-1 |
2023-02-28 |
$-1 |
2022-11-30 |
$1 |
2022-08-31 |
$1 |
2022-05-31 |
$2 |
2022-02-28 |
$1 |
2021-11-30 |
$1 |
2021-08-31 |
$1 |
2021-05-31 |
|
2021-02-28 |
$1 |
2020-11-30 |
$1 |
2020-08-31 |
$2 |
2020-05-31 |
$1 |
2020-02-29 |
$1 |
2019-11-30 |
$2 |
2019-08-31 |
$1 |
2019-05-31 |
$1 |
2019-02-28 |
$0 |
2018-11-30 |
$1 |
2018-08-31 |
$1 |
2018-05-31 |
$1 |
2018-02-28 |
$1 |
2017-11-30 |
$1 |
2017-08-31 |
$1 |
2017-05-31 |
$1 |
2017-02-28 |
$1 |
2016-11-30 |
$1 |
2016-08-31 |
$1 |
2016-05-31 |
$1 |
2016-02-29 |
$1 |
2015-11-30 |
$1 |
2015-08-31 |
$0 |
2015-05-31 |
$1 |
2015-02-28 |
$0 |
2014-08-31 |
$0 |
2014-05-31 |
$0 |
2013-11-30 |
$0 |
2013-08-31 |
$0 |
2013-05-31 |
$0 |
2012-05-31 |
$-0 |
2012-02-29 |
$0 |
2011-11-30 |
$0 |
2011-08-31 |
$0 |
2011-05-31 |
$0 |
2011-02-28 |
$0 |
2010-11-30 |
$0 |
2010-08-31 |
$-0 |
2010-05-31 |
$0 |
2010-02-28 |
$0 |
2009-11-30 |
$0 |
2009-08-31 |
$0 |
2009-05-31 |
|
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical - Outpatient & Home Care |
$0.059B |
$0.059B |
BIOQUAL, Inc., formerly Diagnon Corporation, develops, produces and sells diagnostic test kits incorporating monoclonal antibodies to diagnose certain anemias, infections, and parasitic diseases.
|